| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLE |
Université de Montréal, Centre Hospitalier de l’Univerisité de Montréal, Hôtel-Dieu Hospital, Research Centre (T.-J.H., S.-L.Z., J.S.D.C.), Montréal, Québec, Canada H2W 1T8; Université de Montréal, Maisonneuve-Rosemont Hospital, Research Centre (J.G.F.), Montréal, Québec, Canada H1T 2M4; and Pediatric Nephrology Unit, Harvard Medical School, Massachusetts General Hospital (S.-S.T., J.R.I.), Boston, Massachusetts 02114-3117
Address all correspondence and requests for reprints to: Dr. John S. D. Chan, Université de Montréal, Centre Hospitalier de l’Univerisité de Montréal, Hôtel-Dieu Hospital, Research Centre, Pavillon Masson, 3850 Saint Urbain Street, Montréal, Québec, Canada H2W 1T8. E-mail: . john.chan{at}umontreal.ca
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
-cyano-4-hydroxycinnamic acid), an uncoupler of oxidative phosphorylation (carbonyl cyanide m-chlorophenylhydrazone), a manganese superoxide dismutase mimetic, catalase, and a specific inhibitor of p38 MAPK (SB 203580), but were not affected by an inhibitor of the malate-aspartate shuttle (aminooxyacetate acid). Hydrogen peroxide (
10-5 M) also stimulated p38 MAPK phosphorylation, ANG secretion, and ANG mRNA gene expression, but its stimulatory effect was blocked by catalase and SB 203580. These studies demonstrate that the stimulatory action of high glucose on ANG gene expression in IRPTCs is mediated at least in part via ROS generation and subsequent p38 MAPK activation. |
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
25 mM) containing Ang II (10-8 M) exhibit increased expression of TGFß1, cellular hypertrophy, and extracellular matrix protein accumulation (5, 6, 7, 8, 9, 10). These findings are supported by clinical observations that administration of angiotensin-converting enzyme (ACE) inhibitors or Ang II (AT1 subtype) receptor antagonists reduces proteinuria and slows the progression of nephropathy in diabetic patients (11, 12, 13). The presence of a local intrarenal renin-angiotensin system (RAS) has been well documented. The mRNA components of the RAS, including angiotensinogen (ANG), renin, ACE, and Ang II receptors (AT1 and AT2 subtypes), are expressed in rodent (mouse and rat) immortalized proximal tubular cell lines (14, 15, 16, 17, 18). We have previously shown that high glucose (25 mM) stimulates ANG gene expression in rat immortalized RPTCs (IRPTCs) (19, 20). This stimulatory effect of high glucose can be suppressed by inhibitors of aldose reductase, protein kinase C (PKC) and p38 MAPK (19, 20). Furthermore, we have reported that ACE inhibitors (perindopril and captopril) and an Ang II (AT1) receptor antagonist (losartan) blocked ANG gene expression and prevented the induction of hypertrophy in IRPTCs stimulated by high glucose levels (21). These data support the hypothesis that intrarenal RAS activation may play an important role in the development of renal hypertrophy in diabetes.
Recent studies have shown that hyperglycemia may induce cellular oxidative stress by increasing superoxide or reactive oxygen species (ROS) generation (22). Overproduction of ROS and/or impaired antioxidant defense in poorly controlled diabetes could contribute to endothelial and vascular dysfunction (23, 24). Studies have also shown that elevated glucose levels per se enhance PKC activation, cause oxidative stress, and augment membrane lipid peroxidation in glomeruli (25), suggesting that high glucose might play a role in the induction of glomerular lipid peroxidation. Although high glucose may induce oxidative stress (i.e. ROS generation) in the diabetic kidney (26, 27), the underlying molecular mechanism(s) remains incompletely understood. Brownlee’s group (28, 29) demonstrated recently that hyperglycemia-induced mitochondrial superoxide formation might be the unifying pathway that activates PKC activity, increases intracellular sorbitol and advanced glycated end-product formation, and subsequently induces endothelial cell dysfunction.
In the present studies we investigated whether high glucose levels could evoke cellular ROS generation and modulate ANG gene expression in IRPTCs. Our studies showed that high glucose levels stimulate cellular ROS generation, p38 MAPK phosphorylation, and ANG gene expression in IRPTCs. This high glucose effect on ROS generation and ANG gene expression was blocked by antioxidants, inhibitors of mitochondrial electron transport chain complexes I and II, an inhibitor of glycolysis-derived pyruvate transport into mitochondria, an uncoupler of oxidative phosphorylation, a manganese superoxide dismutase (SOD) mimetic, a catalase (CAT), and a specific inhibitor of p38 MAPK (SB 203580), but not by an inhibitor of the malate-aspartate shuttle. Hydrogen peroxide (H2O2) also stimulated p38 MAPK phosphorylation and ANG gene expression in IRPTCs. Its stimulatory effect was blocked in the presence of CAT and SB 203580. These results demonstrate that high glucose stimulates ANG gene expression in IRPTCs at least in part via the generation of cellular ROS and subsequent activation of the p38 MAPK signal transduction pathway.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
-cyano-4-hydroxycinnamic acid (4-OHCA; an inhibitor of glycolysis-derived pyruvate transport into mitochondria), aminooxyacetate acid (AOAC; an inhibitor of the malate-aspartate shuttle), CAT, and H2O2 were purchased from Sigma-Aldrich Canada Ltd. (Oakville, Canada). SB 203580 (an inhibitor of p38 MAPK kinase) and manganese (III) tetrakis (4-benzoic acid) porphorin chloride (MnTBAP) (a cell-permeable synthetic manganese SOD mimetic) were purchased from Calbiochem (La Jolla, CA). Normal glucose (5 mM) DMEM (catalog no. 12320) and 100x penicillin/streptomycin were purchased from Life Technologies, Inc. (Burlington, Canada). Na125I was obtained from Amersham-Pharmacia Biotech (Baie d’Urfé, Canada). The Phospho Plus p38 MAPK antibody kit was purchased from New England Biolabs, Inc. (Mississauga, Canada). This kit was used for the rapid analysis of p38 MAPK (Thr180/Tyr182) phosphorylation status that functions in the stress-activated protein kinase cascade.
Cell culture
IRPTCs at passages 13–18 were used in the present study. Their characteristics have been described previously (30). These cells express the mRNA and protein of ANG, renin, ACE, and Ang II receptors (30). IRPTCs were grown in 100-mm plastic petri dishes (Life Technologies, Inc.) in normal glucose (i.e. 5 mM glucose DMEM, pH 7.45) supplemented with 10% fetal bovine serum (FBS; Life Technologies, Inc.), 100 U/ml penicillin, and 100 µg/ml of streptomycin until used. The cells were grown in a humidified atmosphere in 95% air/5% CO2 at 37 C and passaged twice a week by harvesting with trypsin/EDTA. Cells were synchronized for 24 h in serum-free 5 mM DMEM at 80–90% confluence before the experiments.
Study design
To determine whether the stimulatory effect of high glucose on ANG gene expression is mediated via ROS generation, cells were preincubated in 5 mM glucose DMEM containing 1% dFBS for 4 h in the absence or presence of tiron (1 x 10-4 M), taurine (5 x 10-3 M), rotenone (5 x 10-6 M), TTFA (1 x 10-4 M), CCCP (5 x 10-6 M), AOAC (1 x 10-4 M), 4-OHCA (2.5 x 10-3 M), MnTBAP (8 x 10-5 M), or CAT (300 U/ml). Then, 20 mM L-glucose or 20 mM D(+)-glucose were added into the culture medium, and the cells were cultured for an additional 30 min or 24 h. At the end of the incubation period, the media were collected and analyzed by RIA for rat ANG (rANG). The cells were harvested for p38 MAPK phosphorylation assay or ANG mRNA quantification. To assess the role of H2O2 on p38 MAPK phosphorylation and ANG gene expression, the cells were incubated with different concentrations of H2O2 (i.e. 10-7–10-4 M) in 5 or 25 mM glucose DMEM containing 1% dFBS for 30 min or 24 h. At the end of the incubation period, the media were collected and assayed by RIA for rANG. The cells were harvested for p38 MAPK phosphorylation assay or ANG mRNA quantification.
Measurement of superoxide or ROS generation in IRPTCs
ROS production was determined by the lucigenin method (31) with minor modifications. Briefly, the cells were preincubated in 5 mM glucose DMEM containing 1% dFBS for 4 h in the absence or presence of tiron (1 x 10-4 M), taurine (5 x 10-3 M), rotenone (5 x 10-6 M), TTFA (1 x 10-4 M), CCCP (5 x 10-6 M), AOAC (1 x 10-4 M), 4-OHCA (2.5 x 10-3 M), MnTBAP (8 x 10-5 M), or CAT (300 U/ml). Then, cells were trypsinized and collected by centrifugation, and the pellet was washed in modified Krebs buffer containing NaCl (130 mM), KCl (5 mM), MgCl2 (1 mM), CaCl2 (1.5 mM), K2HPO4 (1 mM), and HEPES (20 mM), pH 7.4. After washing, the cells were resuspended in Krebs buffer with 1 mg/ml BSA, and the cell concentration was adjusted to 1 x 107 in 900 µl buffer. To measure ROS production, the cell suspension was transferred into plastic tubes and assessed in a luminometer (LB 9507, Berthold, Wildbad, Germany). Measurement was started by an injection of 100 µl lucigenin (final concentration, 5 x 10-4 M) and 25 µl 1 M L-glucose or D-glucose (final concentration, 25 mM) with or without inhibitors, as indicated. Photon emission was counted every 1 min for up to 20 min. Modified Krebs buffer was used as a control (blank). Solutions containing glucose or inhibitors in the absence of cells did not display any significant interference in the lucigenin assay.
Phosphorylation of p38 MAPK in IRPTCs
The activation of p38 MAPK signaling transduction pathways in IRPTCs was evaluated by p38 MAPK phosphorylation with the Phospho Plus p38 MAPK antibody kit (New England Biolabs, Inc., Beverly, MA), as described previously (20). Briefly, 1 x 107 cells were plated in 100-mm petri dishes in 5 mM glucose DMEM containing 10% FBS until 80–90% confluence, then synchronized in 5 mM glucose medium for 24 h. Subsequently, cells were incubated in high glucose in the presence or absence of inhibitors of ROS generation, or H2O2 for 30 min. Then cells were lysed in 700 µl lysis buffer [62.5 mM Tris-HCl, pH 6.8, containing 2% (wt/vol) sodium dodecyl sulfate, 10% glycerol, 50 mM dithiothreitol, and 0.1% (wt/vol) bromophenol blue] and transferred into Eppendorf tubes (Ultident Scientific, St. Laurent, Québec, Canada). The cell lysates were sonicated for 15 sec, heated at 95 C for 5 min, and centrifuged at 12,000 x g for 5 min. Thirty-five microliters of the supernatants were subjected to SDS-10% PAGE, then transferred onto a polyvinylidene difluoride membrane (Hybond-P, Amersham-Pharmacia Biotech). The membrane was initially blotted for phosphorylated p38 MAPK and then reblotted for total p38 MAPK according to the instructions of the supplier (New England Biolabs, Inc.).
RIA for rANG
The RIA for rANG, developed in our laboratory (J.S.D.C.), has been described previously in detail (32). Purified plasma rANG (i.e. 90% pure, as analyzed by SDS-PAGE) and iodinated rANG were used as hormone standard and tracer, respectively. This RIA is specific for intact rat (62–65 kDa) ANG and has no cross-reactivity with pituitary hormone preparations or other rat plasma proteins (32). The lower limit of detection for the RIA is approximately 2 ng rANG. The intra- and interassay coefficients of variation were 9% (n = 10) and 14% (n = 10), respectively.
RT-PCR
Total RNA, isolated with TRIzol reagent (Life Technologies, Inc.) according to the protocol of the supplier and quantified by its absorbance at 260 nm, was used in RT-PCR to quantify the amount of ANG mRNA expressed in IRPTCs. Briefly, 2 µg total RNA were used to synthesize first strand cDNAs by employing the SuperScript preamplification system, following the protocol described by the supplier (Life Technologies, Inc.). Then, the first strand cDNA was diluted with water to a ratio of 1:4, and aliquots were used to amplify the rat ANG and ß-actin cDNA fragments with the PCR core kit according to the supplier’s instructions (La Roche Biochemicals, Inc., Laval, Canada). First strand cDNA (5 µl) and primers of rat ANG (800 nM) and rat ß-actin (100 nM) were added in a final volume of 50 µl PCR mixture (final concentrations, 1x PCR buffer, 0.2 mM deoxy-NTP, 2 mM MgCl2, and 2.0 U Taq DNA polymerase; Life Technologies, Inc.). The PCR mixture was amplified in a Perkin Elmer Cetus (Norwalk, CT) 2400 thermocycler. After denaturation at 94 C for 3 min, rANG and ß-actin cDNA were coamplified in the same tube under the following conditions: 94 C for 1 min, 60 C for 1 min, and 72 C for 1 min and 30 sec. After 30 cycles of amplification, PCRs were further extended at 72 C for 7 min.
The sense and antisense rat ANG primers were 5'-CCT CGC TCT CTG GAC TTA TC-3' and 5'-CAG ACA CTG AGG TGC TGT TG-3', corresponding to the nucleotide sequences of +676 to +695 and +882 to +901 of rANG cDNA (33), respectively. The sense and antisense rat ß-actin primers were 5'-ATG CCA TCC TGC GTC TGG ACC TGG C-3' and 5'-AGC ATT TGC GGT GCA CGA TGG AGG G-3', corresponding to the nucleotide sequences of +155 to +139 of exon 3, and nucleotide sequences of +115 to +139 of exon 5 of the rat ß-actin gene (34), respectively.
To identify rANG and ß-actin cDNA fragments, 10 µl of the PCR product were electrophoresed on 1.2% agarose gels and transferred onto a Hybond XL nylon membrane (Amersham Pharmacia Biotech). Digoxigenin-labeled oligonucleotide 5'-GAG GGG GTC AGC ACG GAC AGC ACC-3', corresponding to nucleotide +775 to +798 of rANG cDNA (33) prepared with a digoxigenin oligonucleotide 3'-end labeling kit (La Roche Biochemicals, Inc.), was used to hybridize the PCR products on the membrane. After stringent washing, the membrane was detected with a digoxigenin luminescent detection kit (La Roche Biochemicals, Inc.) and exposed to Kodak BMR film (Eastman Kodak Co., Rochester, NY). After rANG mRNA analysis, the same membrane was stripped and rehybridized with a ß-actin oligonucleotide probe (sequence: 5'-TCC TGT GGC ATC CAT GAA ACT ACA TTC-3', corresponding to nucleotides +9 to +35 of exon 4 of the rat ß-actin gene) (34). ANG mRNA levels were normalized by corresponding ß-actin mRNA levels.
Statistical analysis
Four to seven separate experiments were performed per protocol, and each treatment group was assayed in triplicate. The data were analyzed with t test or ANOVA. P 
0.05 was regarded as statistically significant.
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
). The addition of tiron (1 x 10-4 M), taurine (5 x 10-3 M), CAT (300 U/ml), or MnTBAP (8 x 10-5 M) to the culture medium abolished high glucose (25 mM)-stimulated ROS generation (Fig. 2A). Likewise, the addition of rotenone (5 x 10-6 M), TTFA (1 x 10-4 M), CCCP (5 x 10-6 M), or 4-OHCA (2.5 x 10-3 M) abolished the stimulatory effect of high glucose, but not the addition of AOAC (1 x 10-4 M; Fig. 2B). These results indicate that high glucose induces ROS generation at least in part via mitochondrial membrane-bound electron transport chain complex I/II, oxidative phosphorylation, and glycolysis-derived pyruvate transport into mitochondria, but not via the malate-aspartate shuttle.
|
|
shows that 25 mM glucose stimulated p38 MAPK phosphorylation in IRPTCs compared with IRPTCs in 5 mM glucose medium. The stimulatory effect of high glucose (25 mM) was blocked in the presence of tiron (1 x 10-4 M), taurine (5 x 10-3 M), MnTBAP (8 x 10-5 M), or SB 203580 (1 x 10-7 M). The addition of rotenone (5 x 10-6 M), TTFA (1 x 10-4 M), CCCP (5 x 10-6 M), or 4-OHCA (2.5 x 10-3 M) also inhibited p38 MAPK phosphorylation in IRPTCs incubated in 25 mM (Fig. 3B). In contrast, the addition of AOAC did not block the stimulatory effect of high glucose on p38 MAPK phosphorylation (data not shown). These results demonstrate that the effect of high glucose on p38 MAPK phosphorylation is mediated at least in part via mitochondrial ROS generation.
|
0.05) after a 24-h incubation period (Fig. 4). The stimulatory effect of high glucose (25 mM) was blocked by taurine (5 x 10-3 M), tiron (1 x 10-4 M), CAT (300 U/ml), MnTBAP (8 x 10-5 M), or SB 203580 (1 x 10-5 M; Fig. 4A) as well as by rotenone (5 x 10-6 M), TTFA (1 x 10-4 M), CCCP (5 x 10-6 M), or 4-OHCA (2.5 x 10-3 M; Fig. 4B). In contrast, the addition of AOAC had no such effect. These studies demonstrate that the hyperglycemia-stimulated secretion of IR-rANG in IRPTCs is mediated at least in part via ROS generation and p38 MAPK activation.
|
shows that 25 mM glucose enhanced ANG mRNA accumulation to levels 2.5-fold higher than those found in control cells cultured in medium containing 5 mM glucose (P 0.01). The addition of taurine, tiron, catalase, MnTBAP, or SB 203580 inhibited ANG mRNA expression stimulated by high glucose. Similarly, the addition of rotenone, TTFA, CCCP, or 4-OHCA also inhibited ANG mRNA expression in IRPTCs incubated in 25 mM glucose medium (Fig. 6). AOAC, however, did not block the stimulatory effect of high glucose on ANG mRNA expression (Fig. 6). These data demonstrate that the stimulatory effect of high glucose levels on cellular ANG mRNA expression is mediated at least in part via ROS generation and p38 MAPK signal transduction pathways.
|
|
shows that H2O2 (i.e. 10-7–10-4 M) stimulated p38 MAPK phosphorylation in IRPTCs incubated in 5 or 25 mM glucose in a dose-dependent manner with a maximal impact observed at 10-4 M. This dose of H2O2 (10-4 M) was then used routinely in all subsequent experiments. Its stimulatory effect on p38 MAPK phosphorylation in IRPTCs was prevented by CAT and SB 203580 (Fig. 7B). These studies demonstrate that H2O2 could directly stimulate p38 MAPK phosphorylation in IRPTCs.
|
), whereas it stimulated IR-rANG secretion in IRPTCs incubated in 25 mM glucose medium in a dose-dependent manner with a maximal effect observed at 10-5–10-4 M (Fig. 8B). Its stimulatory effect was inhibited in the presence of CAT and SB 203580 (Fig. 8C). H2O2 (i.e. 10-4 M) also enhanced ANG mRNA expression in IRPTCs in high glucose medium (Fig. 9). This stimulatory effect on ANG mRNA expression in IRPTCs was blocked in the presence of CAT and SB 203580 (Fig. 9). These studies demonstrate that H2O2 stimulates IR-rANG secretion and ANG mRNA expression in IRPTCs via p38 MAPK activation in high glucose medium.
|
|
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
p38 MAPK is a member of the MAPK superfamily, i.e. the extracellular signal-regulated kinase (p42/p44 MAPKs), p38 MAPK, and stress-activated protein kinases(s) (SAPK)/Jun-N terminal kinase (35). These three kinases represent distinct, but related, signal transduction pathways by which kinases are activated by extracellular signals and then translocated into the nucleus to stimulate specific gene expression (36). Studies have shown that p42/p44 MAPKs are activated by a variety of growth and neurotropic factors and are linked to cell growth and differentiation (37). In contrast, the p38 MAPK and SAPK/Jun-N terminal kinase pathways have been implicated in the cellular response to environmental stress, such as high extracellular osmolarity, UV irradiation, heat shock, and inflammatory cytokines (38, 39, 40). We have previously demonstrated that high glucose levels (i.e. 25 mM) stimulate ANG gene expression and p38 MAPK phosphorylation in IRPTCs in a time-dependent manner that can be prevented by SB 203580 (20). These studies suggest that the stimulatory effect of high glucose (25 mM) on ANG gene expression may be mediated at least in part via the p38 MAPK signal transduction pathway. High glucose was reported to stimulate p38 MAPK phosphorylation consistently in rat mesangial cells and vascular smooth muscle cells (41, 42). The molecular mechanism(s) of high glucose action on p38 MAPK activation in IRPTCs, however, remain(s) undefined.
To elucidate the molecular mechanism(s) by which high glucose activates p38 MAPK and induces ANG gene expression in IRPTCs, we investigated the possibility that high glucose may stimulate superoxide generation and subsequently activate p38 MAPK signaling. The present studies showed that, indeed, 25 mM D-glucose stimulates ROS generation in a time-dependent manner compared with 5 mM glucose, whereas 25 mM L-glucose has no effect (Fig. 1
). Moreover, the addition of antioxidants (tiron, taurine, SOD mimetic, and CAT) and inhibitors of mitochondrial oxidation (rotenone, TTFA, CCCP, and 4-OHCA) prevented ROS generation stimulated by high glucose (Fig. 2, A and B). These results are in agreement with previous studies reporting that antioxidants, superoxide scavengers, and inhibitors of mitochondrial oxidation prevent ROS formation in various cell lines, i.e. vascular smooth muscle cells, endothelial cells, mesangial cells, and murine proximal tubular cells (23, 24, 27, 28, 29, 43). The addition of AOAC did not block the stimulatory effect of high glucose (25 mM) on ROS generation in IRPTCs, indicating that the role of high glucose on ROS generation is not mediated via the malate-aspartate shuttle. These results are in agreement with the findings of Brownlee’s group (29) that AOAC had no influence on mitochondrial ROS generation in bovine endothelial cells. Furthermore, the effective doses of the inhibitors used here were similar to those of reported by Brownlee’s group (29). On the other hand, the inhibitory effect of retenone on ROS generation in IRPTCs is in disagreement with the results of Brownlee’s group (29). The exact reasons for these discrepancies are not known at present. One possible explanation might be that the response to rotenone is specific to the cell type involved (endothelial compared with epithelial cells).
High glucose stimulated p38 MAPK phosphorylation in IRPTCs. This stimulatory effect was suppressed in the presence of antioxidants (i.e. tiron, taurine, CAT, and SOD mimetic), inhibitors of mitochondrial metabolism (i.e. rotenone, TTFA, CCCP, and 4-OHCA), and an inhibitor of p38 MAPK (i.e. SB 203580). These results demonstrate that the stimulatory action of high glucose levels on p38 MAPK phosphorylation is mediated at least in part via mitochondrial ROS generation. Our data are in agreement with previous studies showing that ROS-dependent p38 MAPK activation in various cell types (44, 45, 46, 47). Taken together, these findings support the idea that the high glucose (i.e. 25 mM) effect on p38 MAPK phosphorylation is mediated at least in part via mitochondrial ROS generation.
The addition of antioxidants, inhibitors of mitochondrial electron transport complex I/II, inhibitors of glycolysis-derived pyruvate transport into mitochondria, uncoupler of oxidative phosphorylation, and SB 203580 blocked IR-rANG secretion and ANG mRNA expression in IRPTCs stimulated by high glucose. These studies provide evidence that the effect of high glucose levels on ANG gene expression in IRPTCs may be mediated at least in part via ROS generation and p38 MAPK signal transduction pathways. At present it is not known whether high glucose levels and/or p38 MAPK increase the transcription or affect the stability of ANG mRNA in IRPTCs. Experiments are underway in our laboratory to investigate these possibilities.
Oxidative defense is provided by several key enzymes, such as SOD and CAT, and by chain-breaking scavengers, such as vitamin E, vitamin C, and glutathione (48). SOD is the key antioxidant enzyme involved in the detoxification of superoxide radicals. It is a metalloprotein and its manganese form (MnSOD) is present in mitochondria. Two other forms, containing copper and zinc, have cytoplasmic or extracellular location (49). Our studies revealed that cell-permeable MnSOD mimetic, i.e. MnTBAP, and CAT prevented the stimulatory effect of high glucose on ROS generation, p38 MAPK activation, and ANG mRNA expression in IRPTCs, suggesting that the expression of endogenous MnSOD and CAT is effective in preventing cellular ROS accumulation and subsequently cellular injury.
Recent evidence suggests that certain forms of ROS, such as H2O2, may act as signal molecules. Indeed, studies have shown that H2O2 significantly increases extracellular matrix proteins (collagen types I, III, and IV and fibronectin) and TGFß1 mRNA by approximately 2-fold in human mesangial cells (50). This increase in extracellular matrix mRNA may be mediated via TGFß (50). Our present studies showed that H2O2 stimulates p38 MAPK phosphorylation, IR-rANG secretion, and ANG mRNA expression in IRPTCs. This stimulatory effect of H2O2 is inhibited in the presence of CAT and SB 203580. These studies suggest that the stimulatory impact of ROS on p38 MAPK phosphorylation and ANG gene expression could be mediated at least in part via H2O2 generation in IRPTCs. The molecular mechanism(s) of H2O2 action on p38 MAPK phosphorylation is not clear at present. Investigations are ongoing along this line in our laboratory.
At present we do not know the exact molecular mechanism(s) underlying the stimulatory effect of high glucose (that is, the downstream pathway after p38 MAPK activation) on rat ANG gene expression in IRPTCs. One possibility might be that high glucose induces the phosphorylation of nuclear activating transcription factor-2 (ATF-2) via the p38 MAPK signal transduction pathway. Indeed, studies have shown that p38 MAPK phosphorylates ATF-2 (51, 52). The phosphorylated ATF-2 then forms the heterodimer complex with phosphorylated cAMP-responsive element binding protein (CREB). CREB phosphorylation is induced by high glucose levels via the PKC signal transduction pathway, as demonstrated by Kreisberg et al. (53). The phosphorylated ATF-2/CREB heterodimer then binds to the cAMP-responsive element in the 5'-flanking region of the rANG gene (54, 55) and subsequently enhances gene expression. This possibility is supported by our recent studies which showed that high glucose levels stimulated the phosphorylation of 43-kDa CREB and ATF-2 in IRPTCs (56). Indeed, experiments are ongoing in our laboratory to explore the downstream molecular mechanism(s) of the stimulatory effect of high glucose on ANG gene expression in IRPTCs.
In summary, the present studies showed that high glucose levels directly stimulate ROS generation, p38 MAPK phosphorylation, and ANG gene expression in IRPTCs. The addition of antioxidants, inhibitors of mitochondrial oxidation, and SB 203580 blocked the stimulatory effect of high glucose, implicating mitochondrial ROS and the p38 MAPK signal transduction pathway in up-regulation of renal ANG gene expression under hyperglycemic conditions. These results suggest that blockade of ROS generation may represent a novel therapeutic approach to prevent or attenuate glucose-induced ANG gene expression and, consequently, the development of diabetic nephropathy. However, it remains to be seen whether long-term blockade of ROS generation may indeed be beneficial in the treatment of diabetic nephropathy. This interesting possibility warrants further investigation.
|
Acknowledgments |
|---|
|
Footnotes |
|---|
S.-L.Z. is the recipient of a Canadian Institutes of Health Research Doctoral Research Award.
Abbreviations: ACE, Angiotensin-converting enzyme; ANG, angiotensinogen; Ang II, angiotensin II; AOAC, aminooxyacetate acid; ATF-2, activating transcription factor-2; CAT, catalase; CCCP, carbonyl cyanide m-chlorophenylhydrazone; CREB, cAMP-responsive element binding protein; dFBS, depleted FBS; FBS, fetal bovine serum; IRPTC, immortalized renal proximal tubular cell; IR-rANG, immunoreactive rat angiotensinogen; MnTBAP, manganese (III) tetrakis (4-benzoic acid) porphorin chloride; 4-OHCA, -cyano-4-hydroxycinnamic acid; PKC, protein kinase C; RAS, renin-angiotensin system; ROS, reactive oxygen species; RPTC, renal proximal tubular cell; SAPK, stress-activated protein kinase; SOD, superoxide dismutase; TTFA, thenoyltrifluoroacetone.
Received January 16, 2002.
Accepted for publication April 8, 2002.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
-induced p38 MAPK kinase activation and p38 MAPK kinase-mediated IL-8 production by human pulmonary vascular endothelial cells. Br J Pharmacol 132:270–276[CrossRef][Medline]
This article has been cited by other articles:
 |
|
 |
|
  T. Kurihara, Y. Ozawa, N. Nagai, K. Shinoda, K. Noda, Y. Imamura, K. Tsubota, H. Okano, Y. Oike, and S. Ishida Angiotensin II Type 1 Receptor Signaling Contributes to Synaptophysin Degradation and Neuronal Dysfunction in the Diabetic Retina Diabetes, August 1, 2008; 57(8): 2191 - 2198. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. A Stevens, S. Saad, P. Poronnik, C. A Fenton-Lee, T. S Polhill, and C. A Pollock The role of SGK-1 in angiotensin II-mediated sodium reabsorption in human proximal tubular cells Nephrol. Dial. Transplant., June 1, 2008; 23(6): 1834 - 1843. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Tran, Y.-W. Chen, I. Chenier, J. S.D. Chan, S. Quaggin, M.-J. Hebert, J. R. Ingelfinger, and S.-L. Zhang Maternal Diabetes Modulates Renal Morphogenesis in Offspring J. Am. Soc. Nephrol., May 1, 2008; 19(5): 943 - 952. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-L. Brezniceanu, F. Liu, C.-C. Wei, I. Chenier, N. Godin, S.-L. Zhang, J. G. Filep, J. R. Ingelfinger, and J. S.D. Chan Attenuation of Interstitial Fibrosis and Tubular Apoptosis in db/db Transgenic Mice Overexpressing Catalase in Renal Proximal Tubular Cells Diabetes, February 1, 2008; 57(2): 451 - 459. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Liu, M.-L. Brezniceanu, C.-C. Wei, I. Chenier, S. Sachetelli, S.-L. Zhang, J. G. Filep, J. R. Ingelfinger, and J. S.D. Chan Overexpression of Angiotensinogen Increases Tubular Apoptosis in Diabetes J. Am. Soc. Nephrol., February 1, 2008; 19(2): 269 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kobori, M. Nangaku, L. G. Navar, and A. Nishiyama The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease Pharmacol. Rev., September 1, 2007; 59(3): 251 - 287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Pelletier and L. Coderre Ketone bodies alter dinitrophenol-induced glucose uptake through AMPK inhibition and oxidative stress generation in adult cardiomyocytes Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1325 - E1332. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Hodroj, L. Legedz, N. Foudi, C. Cerutti, M.-C. Bourdillon, P. Feugier, M. Beylot, J. Randon, and G. Bricca Increased Insulin-Stimulated Expression of Arterial Angiotensinogen and Angiotensin Type 1 Receptor in Patients With Type 2 Diabetes Mellitus and Atheroma Arterioscler. Thromb. Vasc. Biol., March 1, 2007; 27(3): 525 - 531. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Cambonie, B. Comte, C. Yzydorczyk, T. Ntimbane, N. Germain, N. L. O. Le, P. Pladys, C. Gauthier, I. Lahaie, D. Abran, et al. Antenatal antioxidant prevents adult hypertension, vascular dysfunction, and microvascular rarefaction associated with in utero exposure to a low-protein diet Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2007; 292(3): R1236 - R1245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Camello-Almaraz, P. J. Gomez-Pinilla, M. J. Pozo, and P. J. Camello Mitochondrial reactive oxygen species and Ca2+ signaling Am J Physiol Cell Physiol, November 1, 2006; 291(5): C1082 - C1088. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-C. Wei, S.-L. Zhang, Y.-W. Chen, D.-F. Guo, J. R. Ingelfinger, K. Bomsztyk, and J. S. D. Chan Heterogeneous Nuclear Ribonucleoprotein K Modulates Angiotensinogen Gene Expression in Kidney Cells J. Biol. Chem., September 1, 2006; 281(35): 25344 - 25355. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. McGowan, S. R. Dunn, B. Falkner, and K. Sharma Stimulation of Urinary TGF-{beta} and Isoprostanes in Response to Hyperglycemia in Humans Clin. J. Am. Soc. Nephrol., March 1, 2006; 1(2): 263 - 268. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Lupi, S. D. Guerra, M. Bugliani, U. Boggi, F. Mosca, S. Torri, S. D. Prato, and P. Marchetti The direct effects of the angiotensin-converting enzyme inhibitors, zofenoprilat and enalaprilat, on isolated human pancreatic islets Eur. J. Endocrinol., February 1, 2006; 154(2): 355 - 361. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Thomas, C. Tikellis, W. M. Burns, K. Bialkowski, Z. Cao, M. T. Coughlan, K. Jandeleit-Dahm, M. E. Cooper, and J. M. Forbes Interactions between Renin Angiotensin System and Advanced Glycation in the Kidney J. Am. Soc. Nephrol., October 1, 2005; 16(10): 2976 - 2984. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-C. Wei, D.-F. Guo, S.-L. Zhang, J. R. Ingelfinger, and J. S.D. Chan Heterogenous Nuclear Ribonucleoprotein F Modulates Angiotensinogen Gene Expression in Rat Kidney Proximal Tubular Cells J. Am. Soc. Nephrol., March 1, 2005; 16(3): 616 - 628. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.-J. Hsieh, P. Fustier, C.-C. Wei, S.-L. Zhang, J. G Filep, S.-S. Tang, J. R Ingelfinger, I G. Fantus, P. Hamet, and J. S D Chan Reactive oxygen species blockade and action of insulin on expression of angiotensinogen gene in proximal tubular cells J. Endocrinol., December 1, 2004; 183(3): 535 - 550. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-H. Woo, J.-H. Lim, and J.-H. Kim Lipopolysaccharide Induces Matrix Metalloproteinase-9 Expression via a Mitochondrial Reactive Oxygen Species-p38 Kinase-Activator Protein-1 Pathway in Raw 264.7 Cells J. Immunol., December 1, 2004; 173(11): 6973 - 6980. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Dong, J. I. Everitt, S. S. Lau, and T. J. Monks Induction of ERK1/2 and Histone H3 Phosphorylation within the Outer Stripe of the Outer Medulla of the Eker Rat by 2,3,5-Tris-(Glutathion-S-yl)hydroquinone Toxicol. Sci., August 1, 2004; 80(2): 350 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.-J. Hsieh, P. Fustier, S.-L. Zhang, J. G. Filep, S.-S. Tang, J. R. Ingelfinger, I. G. Fantus, P. Hamet, and J. S. D. Chan High Glucose Stimulates Angiotensinogen Gene Expression and Cell Hypertrophy via Activation of the Hexosamine Biosynthesis Pathway in Rat Kidney Proximal Tubular Cells Endocrinology, October 1, 2003; 144(10): 4338 - 4349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Mason and N. A. Wahab Extracellular Matrix Metabolism in Diabetic Nephropathy J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1358 - 1373. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhang, H. Han, J. Wang, H. Wang, B. Yang, and Z. Wang Impairment of Human Ether-a-Go-Go-related Gene (HERG) K+ Channel Function by Hypoglycemia and Hyperglycemia. SIMILAR PHENOTYPES BUT DIFFERENT MECHANISMS J. Biol. Chem., March 14, 2003; 278(12): 10417 - 10426. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
, 5 mM D-glucose; 
, 25 mM D-glucose; 
, 25 mM L-glucose.
